| Latest | F'cast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | -53.7% | n/a |
| ROCE | n/a |
| Latest | F'cast | |
|---|---|---|
| P/E | n/a | n/a |
| PEG | n/a | n/a |
| Pr/Revenue | 6.9 | n/a |
| Pr/Book | 8.9 |
| Latest | F'cast | |
|---|---|---|
| Revenue | 7.4% | n/a |
| PBT | n/a | n/a |
| EPS | n/a | n/a |
| DPS | n/a | n/a |
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Mar-22 | 4.80 | (1.33) | (4.60)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Mar-23 | 2.90 | (2.86) | (10.00)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Mar-24 | 1.14 | (2.29) | (3.90)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Mar-25 | 1.97 | (1.63) | (1.70)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Mar-26 | 2.11 | (1.15) | (1.20)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| REPLACEMENT: Final Results | 15-Sep-2026 | 15:42 | RNS |
| Final Results | 14-Sep-2026 | 07:00 | RNS |
| Grant of Canadian Patent for OptiMAL | 09-Sep-2026 | 12:30 | RNS |
No deals were found in the last 28 days.
| Currency | UK Pounds |
| Share Price | 10.75p |
| Change Today | -0.50p |
| % Change | -4.44 % |
| 52 Week High | 19.25 |
| 52 Week Low | 9.13 |
| Volume | 231,782 |
| Shares Issued | 125.16m |
| Market Cap | £13.45m |
| RiskGrade | 464 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 16:27 | 22,621 @ 10.65p |
| 16:27 | 3,500 @ 10.89p |
| 10:24 | 19,001 @ 10.92p |
| 09:53 | 100,000 @ 10.56p |
| 09:53 | 20,000 @ 10.99p |
| Chair | Simon Gordon Douglas |
| CEO | Adrian Kinkaid |
You are here: research